Search
for
Sort by
Research 30 of 44
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Genomic and transcriptomic landscape to decipher the genetic basis of hyperpigmentation in Lanping black-boned sheep (Ovis aries)
- Sun behaviors and quality of life after first cutaneous melanoma diagnosis
- Empirical evidence of observer bias in randomized clinical trials: updated and expanded analysis of trials with both blinded and non-blinded outcome assessors
- PD20-08 INVESTIGATION OF SEXUAL DYSFUNCTION LINKED TO FINASTERIDE USE: A PHARMACOVIGILANCE ANALYSIS
- Sunscreen: Cosmetic or medical therapy?
- 8 Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence
- ROR2 regulates self-renewal and maintenance of hair follicle stem cells
- Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- Hierarchical patterning modes orchestrate hair follicle morphogenesis
- Differential effects of Wnt5a on the proliferation, differentiation and inflammatory response of keratinocytes
- AIMP1-Derived Peptide Secreted from Hair Follicle Stem Cells Promotes Hair Growth by Activating Dermal Papilla Cells
- Hoxc13 polyglycine repeat gain-of-function drives mammalian integument evolution by altering targeted genes and interactions
- SPT6 maintains epidermal homeostasis by inhibiting an NF-κB-positive feedback loop to prevent excessive inflammation
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes
- Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review
- Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database
- Drug-induced vitiligo: a real-world pharmacovigilance analysis of the FAERS database
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms
- Finasteride Use: Evaluation of Depression and Suicide Risk
- Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications
- Biological Function of Long Non-coding RNA (LncRNA) Xist
- WNT Signaling in Disease
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance